Clinical Significance of Disease Flares in Patients with Non-small Cell Lung Cancer with Positive EGFR Mutations Following the Suspension of Treatment with Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.